Practical use of osimertinib in Japanese patients with EGFR T790M mutation positive advanced non-small-cell lung cancer

被引：0
|
作者：
Kotake, M. [1 ]
Murakami, H. [1 ]
Naito, T. [1 ]
Takahashi, T. [1 ]
Kenmotsu, H. [1 ]
Ono, A. [1 ]
Wakuda, K. [1 ]
Nakashima, K. [1 ]
Omori, S. [1 ]
机构：
[1] Shizuoka Canc Ctr, Thorac Oncol, Shizuoka, Japan
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
456P
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Managing EGFR T790M Mutation in Advanced Non-Small Cell Lung Cancers in THAILAND
    Prempree, T.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2136 - S2136
  • [42] ROR1 as a novel therapeutic target for EGFR-mutant non-small-cell lung cancer patients with the EGFR T790M mutation
    Karachaliou, Niki
    Gimenez-Capitan, Ana
    Drozdowskyj, Ana
    Viteri, Santiago
    Moran, Teresa
    Carcereny, Enric
    Massuti, Bartomeu
    Vergnenegre, Alain
    de Marinis, Filippo
    Angel Molina, Miguel
    Teixido, Cristina
    Rosell, Rafael
    TRANSLATIONAL LUNG CANCER RESEARCH, 2014, 3 (03) : 122 - 130
  • [43] Loss of T790M Mutation is Associated with Early Progression to Osimertinib in Chinese Advanced NSCLC Patients Harboring EGFR T790M
    Zhao, S.
    Jiang, T.
    Li, X.
    Zhao, C.
    Su, C.
    Ren, S.
    Zhou, C.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S410 - S410
  • [44] EGFR T790M resistance mutation in non small-cell lung carcinoma
    Denis, Marc G.
    Vallee, Audrey
    Theoleyre, Sandrine
    CLINICA CHIMICA ACTA, 2015, 444 : 81 - 85
  • [45] Risk Factors for Developing T790M Mutation in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer
    Ouyang, W.
    Xie, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E526 - E526
  • [46] Osimertinib-induced Stevens-Johnson syndrome in a patient with EGFR T790M mutation-positive non-small cell lung cancer
    Lin, Yi-Tsz
    Chu, Chia-Yu
    LUNG CANCER, 2019, 129 : 110 - 111
  • [47] Role of T790M Mutation in EGFR-TKI Rechallenge for Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer
    Zhang, Qiu-Yi
    Ke, E-E
    Deng, Wei
    Niu, Fei-Yu
    Zhao, Ning
    Su, Jian
    Chen, Zhi-Hong
    Yang, Jin-Ji
    Xu, Chong-Rui
    Yan, Hong-Hong
    Wu, Yi-Long
    Zhou, Qing
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S271 - S271
  • [48] ASTRIS: A real world treatment study of osimertinib in patients (pts) with EGFR T790M positive non-small cell lung cancer (NSCLC).
    De Marinis, Filippo
    Cho, Byoung Chul
    Kim, Dong-Wan
    Kim, Sang-We
    Hochmair, Maximilian J.
    Metro, Giulio
    Vansteenkiste, Johan F.
    Vicente, David
    Solomon, Benjamin J.
    Cheema, Parneet K.
    Freitas, Helano C.
    Provencio, Mariano
    Chen, Yuh-Min
    Wu, Yi-Long
    Milner, Alvin
    Rigas, James R.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [49] Pretreatment EGFR T790M Mutation and BRCA1 mRNA Expression in Erlotinib-Treated Advanced Non-Small-Cell Lung Cancer Patients with EGFR Mutations
    Rosell, Rafael
    Angel Molina, Miguel
    Costa, Carlota
    Simonetti, Sara
    Gimenez-Capitan, Ana
    Bertran-Alamillo, Jordi
    Mayo, Clara
    Moran, Teresa
    Mendez, Pedro
    Cardenal, Felipe
    Isla, Dolores
    Provencio, Mariano
    Cobo, Manuel
    Insa, Amelia
    Garcia-Campelo, Rosario
    Reguart, Noemi
    Majem, Margarita
    Viteri, Santiago
    Carcereny, Enric
    Porta, Ruth
    Massuti, Bartomeu
    Queralt, Cristina
    de Aguirre, Itziar
    Miguel Sanchez, Jose
    Sanchez-Ronco, Maria
    Luis Mate, Jose
    Ariza, Aurelio
    Benlloch, Susana
    Javier Sanchez, Jose
    Bivona, Trever G.
    Sawyers, Charles L.
    Taron, Miquel
    CLINICAL CANCER RESEARCH, 2011, 17 (05) : 1160 - 1168
  • [50] Spatiotemporal T790M Heterogeneity in a Patient with EGFR-Mutant Non-Small-Cell Lung Cancer
    Hata, Akito
    Masago, Katsuhiro
    Katakami, Nobuyuki
    Imai, Yukihiro
    Yatabe, Yasushi
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (08) : E64 - E65
12345